Ian Richard Cook

US Patent:

8380315, Feb 19, 2013

Filed:

Oct 5, 2010

Appl. No.:

12/898686

Inventors:

Christopher DeGiorgio - Valencia CA, US
Ian A. Cook - Los Angeles CA, US
Alejandro Covalin - Culver City CA, US
Patrick R. Miller - Santa Monica CA, US
Lara Schrader - Pacific Palisades CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61N 1/00

US Classification:

607 45

Abstract:

The present disclosure relates to methods, devices and systems used for the treatment of mood, anxiety, post traumatic stress disorder, and cognitive and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, cutaneous methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, infraorbital, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.

US Patent:

20110106220, May 5, 2011

Filed:

Oct 5, 2010

Appl. No.:

12/898696

Inventors:

Christopher DeGiorgio - Valencia CA, US
Ian A. Cook - Los Angeles CA, US
Leon Ekchian - Glendale CA, US

Assignee:

The Regents of the University of California - Oakland CA
Neurosigma, Inc. - Los Angeles CA

International Classification:

A61N 1/36

US Classification:

607 72

Abstract:

The present disclosure relates to methods, devices and systems used for the treatment of neurological disorders via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infratrochlear, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal, infraorbital, and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein. Systems and devices configured for therapeutic stimulation of the branches of the trigeminal nerves, such as the superficial trigeminal nerve, and their methods of application are also described.

US Patent:

20110112603, May 12, 2011

Filed:

Oct 5, 2010

Appl. No.:

12/898685

Inventors:

Christopher DEGIORGIO - Valencia CA, US
Ian A. COOK - Los Angeles CA, US
Leon EKCHIAN - Glendale CA, US

Assignee:

The Regents of the University of California - Oakland CA
Neurosigma, Inc. - Los Angeles CA

International Classification:

A61N 1/36
A61N 1/05

US Classification:

607 45, 607116

Abstract:

The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.

US Patent:

20110218589, Sep 8, 2011

Filed:

Oct 5, 2010

Appl. No.:

12/898675

Inventors:

Christopher DeGIORGIO - Valencia CA, US
Ian A. COOK - Los Angeles CA, US
Alejandro COVALIN - Culver City CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61N 1/36
A61N 1/04

US Classification:

607 45, 607115

Abstract:

The present disclosure relates to methods, devices, and systems used for the treatment of and/or promoting recovery from various neurological disorders and conditions, including epilepsy and other seizure disorders and movement and other related disorders; for promoting recovery from acute or chronic brain injury (e.g. stroke, hypoxia/ischemia, head trauma, subarachnoid hemorrhage, and other forms of brain injury, for awakening and/or promoting the recovery of patients in various levels of coma, altered mental status or vegetative state); or for promoting recovery from chronic daily headache and migraine and related disorders via external (cutaneous) stimulation of the sensory branches of the trigeminal nerve in the face and forehead. More specifically, devices and electrode assemblies configured for stimulation of the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and infratrochlear nerves are disclosed.